- Home
- BVFL vs FBRX Comparison
BVFL vs FBRX Comparison
Compare BVFL & FBRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BVFL
- FBRX
- Stock Information
- Founded
- BVFL 1873
- FBRX N/A
- Country
- BVFL United States
- FBRX United States
- Employees
- BVFL N/A
- FBRX N/A
- Industry
- BVFL Savings Institutions
- FBRX Biotechnology: Pharmaceutical Preparations
- Sector
- BVFL Finance
- FBRX Health Care
- Exchange
- BVFL Nasdaq
- FBRX Nasdaq
- Market Cap
- BVFL 150.2M
- FBRX 154.5M
- IPO Year
- BVFL N/A
- FBRX N/A
- Fundamental
- Price
- BVFL $16.72
- FBRX $13.21
- Analyst Decision
- BVFL
- FBRX Strong Buy
- Analyst Count
- BVFL 0
- FBRX 3
- Target Price
- BVFL N/A
- FBRX $68.00
- AVG Volume (30 Days)
- BVFL 39.9K
- FBRX 81.5K
- Earning Date
- BVFL 10-20-2025
- FBRX 11-13-2025
- Dividend Yield
- BVFL N/A
- FBRX N/A
- EPS Growth
- BVFL 27.09
- FBRX N/A
- EPS
- BVFL 1.07
- FBRX N/A
- Revenue
- BVFL $38,333,000.00
- FBRX N/A
- Revenue This Year
- BVFL N/A
- FBRX N/A
- Revenue Next Year
- BVFL N/A
- FBRX N/A
- P/E Ratio
- BVFL $15.42
- FBRX N/A
- Revenue Growth
- BVFL 2.48
- FBRX N/A
- 52 Week Low
- BVFL $13.53
- FBRX $4.11
- 52 Week High
- BVFL $18.19
- FBRX $28.68
- Technical
- Relative Strength Index (RSI)
- BVFL 58.31
- FBRX 68.54
- Support Level
- BVFL $16.47
- FBRX $10.11
- Resistance Level
- BVFL $16.74
- FBRX $11.57
- Average True Range (ATR)
- BVFL 0.20
- FBRX 0.93
- MACD
- BVFL -0.04
- FBRX 0.18
- Stochastic Oscillator
- BVFL 70.45
- FBRX 94.76
About BVFL BV Financial Inc.
BV Financial Inc is a federally-chartered savings and loan holding company engaged in offering traditional financial services to consumers and businesses. The company offers savings, interest checking, money market, personal and business checking, non-interest checking, education savings, small business checking, and business checking and certificates of deposit and IRA certificates of deposit. The Company's sources of revenue are derived from interest and dividends earned on loans and investment securities.
About FBRX Forte Biosciences Inc.
Forte Biosciences Inc is a biopharmaceutical company that is advancing through preclinical trials its product candidate, FB-102, which is a proprietary therapeutic molecule with potentially broad autoimmune applications in such indications as graft-versus-host disease (GvHD), vitiligo, alopecia areata, and type 1 diabetes (T1D).